On December 13th, 2019, world's leading medical healthcare safety expertise UL signed MoU and awarded Witness Test Program (WTDP) Lab certificate to Ningbo David Medical Device Co., Ltd (Ningbo David) for its pioneering work in the medical industry. This is the first UL WTDP certificate awarding in the field of infant incubator devices worldwide.
The WTDP certification for Ningbo David symbolizes a smoother, more efficient and high-qualified customized testing service collaboration for the future. Based on the WTDP certification, Ningbo David can make full use of its equipped lab devices to conduct product testing program under the on-site witness of UL technical engineers. This will significantly save time on both the traditional testing period and global market access.
Ningbo David Medical Device Co., Ltd, is the leading domestic manufacturer of Infant Incubators and has been devoted to baby care devices development and manufacturing since 1992. During its more than 27 years of contributions to baby care devices industry, Ningbo David's insistence on innovation has developed the company into one of the world's leading infant incubator medical device manufacturers and has earned the operation a high worldwide reputation.
UL, the world-famous independent 3rd-party testing and certification institution, has been committed to medical device industry standard development and quality assurance since 1990. With its world's leading technical testing capability, UL has successfully assisted hundreds of thousands of medical device manufacturers to have access to global market. UL also plays an important role in improving medical device industry innovation.
Based on the long-term collaboration during the past few years, UL officially signed MoU with Ningbo David, which indicates the deeper strategic business partnership establishment. As the representative of UL, Gary Gu, UL Life and Health Sciences Division Asia Pacific General Manager, signed the MoU (Memorandum of Understanding) with Ningbo David Medical Device Co., Ltd General Manager Mr. Chen Zai Hong. Under the MoU, UL will make full use of its world's leading technical strength and full life-cycle business solution to support to improve Ningbo David's international competitiveness and improve global market access.
This MoU is not only the symbol of solid partnership between UL and Ningbo David, but also indicates UL's aspiration for supporting more domestic medical device manufacturers to achieve success in the medical device industry.
The high-level business discovery session was launched between leaders before signing MoU. The management teams reviewed past collaboration as well as future business and opportunities.
Based on the win-win business partnership, Ningbo David General Manager, Mr. Chen Zai Hong stated: "High-quality assurance and continuous innovation are always David's intention in the more than 20 years development. The reason why David chose UL as the global business strategic partner is that David values UL's prompt response, effective colleboration, high-quality service and world-leading technical background. David sincerely hopes to maintain the closer relationship with UL in the field of product innovation, engineer training and global market expansion."
In the past 10 years' of industry development and transformation, UL insists on innovation and has grown from a traditional single testing and certification operation to a full life-cycle integration business solution. UL's services cover research and design, testing and certification, market access, quality assurance, post-market surveillance, and supporting more domestic medical device manufacturers to realize faster market expansion.
UL Life and Health Sciences Division Asia Pacific General Manager, Gary Gu:
"UL values the collaborative relationship with Ningbo David all the time. In Greater China's fast-growing innovative healthcare era, UL is greatly looking forward to develop in-depth cooperation with local medical device manufacturers. Fully leveraging UL's leading technical background, experience and resources, local medical device manufacturers can be beneficially supported by UL to develop competitive products and make faster access to global market. Signing the MoU with Ningbo David is the milestone of new stage between UL and Ningbo David, the establishment of strategic business partnership will create more possibilities for both in the near future."
UL will continue to be committed to providing high-standard testing and certification services to domestic medical device manufacturers as well as actively promote medical device healthcare innovative industry, with the aim of supporting more companies' global market access.
About UL Life and Health Sciences
The UL Life and Health Sciences division is dedicated to healthcare industry innovation by helping clients with their biggest challenges in regulatory management, market access, and connected device risk i.e. safety, security, usability, and interoperability. We ensure that medical devices are safe to deploy and use in an increasingly patient-centric and connected environment.
UL brings decades of the most advanced technical, regulatory and clinical expertise to solve the toughest challenges in the market with the goal of improving access to advanced safe healthcare around the world.
Ningbo David Medical Device Co., Ltd
Ningbo Dawei Medical Devices Co., Ltd. was established in 1992. It is a high-tech enterprise integrating independent research, production and sales. It mainly produces baby incubators, transport incubators, infant radiation warmers, and neonatal jaundice treatment series. Equipment and other baby care medical devices. After nearly 27 years of pioneering and development, David has now become a professional manufacturer of baby care equipment such as baby incubators in China, and is renowned throughout the country for its high quality products and services. The "David" brand has been deeply rooted in the hearts of users, has an absolute leading edge in the domestic and international markets, and has always adhered to technological innovation and quality services. With a rigorous, efficient and reliable corporate purpose, it is committed to becoming the world's largest baby care device production base.